ENDOLOGIX INC /DE/·4

Feb 1, 4:03 PM ET

Thompson Matthew 4

4 · ENDOLOGIX INC /DE/ · Filed Feb 1, 2019

Insider Transaction Report

Form 4
Period: 2019-01-31
Thompson Matthew
Chief Medical Officer
Transactions
  • Award

    Common Stock

    2019-01-31+19,142542,319 total
Footnotes (1)
  • [F1]100% of the time-based restricted stock unit award shall vest on January 31, 2020 and shall settle in shares of common stock.

Documents

1 file
  • 4
    wf-form4_154905501691166.xmlPrimary

    FORM 4